This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2001 Sep 22;358(9286):1010.

doi: 10.1016/s0140-6736(01)06131-1.

Safety profile of bupropion for chronic obstructive pulmonary disease

PMID: 11586980
DOI: 10.1016/s0140-6736(01)06131-1

Comment

Safety profile of bupropion for chronic obstructive pulmonary disease

I A Campbell. Lancet. 2001.

. 2001 Sep 22;358(9286):1010.

doi: 10.1016/s0140-6736(01)06131-1.

Author

PMID: 11586980
DOI: 10.1016/s0140-6736(01)06131-1

No abstract available

PubMed Disclaimer

Comment on

Place of bupropion in smoking-cessation therapy.
Silagy C, Formica N. Silagy C, et al. Lancet. 2001 May 19;357(9268):1550. doi: 10.1016/S0140-6736(00)04781-4. Lancet. 2001. PMID: 11377641 No abstract available.
Smoking cessation in patients with chronic obstructive pulmonary disease: a double-blind, placebo-controlled, randomised trial.
Tashkin D, Kanner R, Bailey W, Buist S, Anderson P, Nides M, Gonzales D, Dozier G, Patel MK, Jamerson B. Tashkin D, et al. Lancet. 2001 May 19;357(9268):1571-5. doi: 10.1016/s0140-6736(00)04724-3. Lancet. 2001. PMID: 11377644 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
Medical
- MedlinePlus Health Information